Pep Therapy
Paris, FR · 5 known investors
Find your way into Pep Therapy
PEP-Therapy develops peptide-based therapeutic candidates for oncology, with a lead product in clinical trials targeting solid tumors including ovarian cancer and pancreatic cancer. The company uses an intracellular delivery technology platform to deliver peptides that restore apoptosis in cancer cells.
Investors · 5
In the news
Frequently asked questions
- What does Pep Therapy do?
- PEP-Therapy develops peptide-based therapeutic candidates for oncology, with a lead product in clinical trials targeting solid tumors including ovarian cancer and pancreatic cancer. The company uses an intracellular delivery technology platform to deliver peptides that restore apoptosis in cancer cells.
- Who are Pep Therapy's investors?
- Pep Therapy's investors include Italian Angels for Growth, Doorway, Seventure Partners, Biotech Investments S.R.O, CAP HORN VC.
- Where is Pep Therapy headquartered?
- Pep Therapy is headquartered in Paris, FR.